Literature DB >> 31676984

Glucose-Responsive Microspheres as a Smart Drug Delivery System for Controlled Release of Insulin.

Jiaojiao Yu1,2,3, Qiongyan Wang1, Haofan Liu1, Xiaosong Shan2, Ziyan Pang3, Pengjin Song1, Feng Niu4, Liandong Hu5,6.   

Abstract

BACKGROUND AND OBJECTIVES: Diabetes mellitus, a disease of glucose regulation, has become one of the most common medical problems in the world. At present, alternative therapy for diabetes has, to a large extent, been widely concerned with the improvement of treatment efficacy. The aims of this study were to characterize and evaluate the surface morphology of the novel glucose-responsive injectable microspheres containing insulin, along with their in vitro release and in vivo efficacy.
METHODS: In this study, glucose-responsive microspheres as an emerging smart drug delivery system for controlled release of insulin were developed by an improved water-in-oil-in-water (W/O/W) double emulsion preparation method. Here, methoxypolyethylene glycol-hydrazone-4-methoxypolyethylene glycol benzoate (mPEG-Hz-mPEG4AB) was synthesized as a pH-responsive carrier.
RESULTS: The microspheres had a good spherical structure with a particle size of 5 ~ 10 μm. Approximately 61% of insulin was released in 15 h under a high glucose environment but was barely released within the normal glucose range in in vitro studies. After a subcutaneous injection of insulin microspheres in rats, blood glucose levels rapidly decreased within 2 h and could be maintained for 2 days in the normal range. Histopathological evaluation indicated that the microspheres were almost non-irritating.
CONCLUSIONS: The pH-responsive mPEG-Hz-mPEG4AB could be used as an efficient insulin microsphere carrier, and the optimized microspheres had good morphology and sustained hypoglycemic effect.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31676984     DOI: 10.1007/s13318-019-00588-2

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  22 in total

1.  pH-sensitive peptide hydrogel for glucose-responsive insulin delivery.

Authors:  Xue Li; Mian Fu; Jun Wu; Chenyu Zhang; Xin Deng; Arvind Dhinakar; Wenlong Huang; Hai Qian; Liang Ge
Journal:  Acta Biomater       Date:  2017-01-06       Impact factor: 8.947

2.  Glucose- and H2O2-Responsive Polymeric Vesicles Integrated with Microneedle Patches for Glucose-Sensitive Transcutaneous Delivery of Insulin in Diabetic Rats.

Authors:  Zaizai Tong; Junyi Zhou; Jiaxing Zhong; Qiuju Tang; Zhentao Lei; Haipeng Luo; Pianpian Ma; Xiangdong Liu
Journal:  ACS Appl Mater Interfaces       Date:  2018-05-31       Impact factor: 9.229

3.  Construction and application of a pH-sensitive nanoreactor via a double-hydrophilic multiarm hyperbranched polymer.

Authors:  Lijuan Zhu; Yunfeng Shi; Chunlai Tu; Ruibing Wang; Yan Pang; Feng Qiu; Xinyuan Zhu; Deyue Yan; Lin He; Chengyu Jin; Bangshang Zhu
Journal:  Langmuir       Date:  2010-06-01       Impact factor: 3.882

4.  Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.

Authors:  Tomáš Etrych; Lubomír Kovář; Jiří Strohalm; Petr Chytil; Blanka Ríhová; Karel Ulbrich
Journal:  J Control Release       Date:  2011-06-15       Impact factor: 9.776

5.  pH-sensitive multi-PEGylated block copolymer as a bioresponsive pDNA delivery vector.

Authors:  Tsz Chung Lai; Younsoo Bae; Takayuki Yoshida; Kazunori Kataoka; Glen S Kwon
Journal:  Pharm Res       Date:  2010-03-19       Impact factor: 4.200

Review 6.  Controlled release of biologics for the treatment of type 2 diabetes.

Authors:  Caslin A Gilroy; Kelli M Luginbuhl; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2015-12-02       Impact factor: 9.776

7.  Selective intracellular delivery of proteasome inhibitors through pH-sensitive polymeric micelles directed to efficient antitumor therapy.

Authors:  S Quader; H Cabral; Y Mochida; T Ishii; X Liu; K Toh; H Kinoh; Y Miura; N Nishiyama; K Kataoka
Journal:  J Control Release       Date:  2014-06-02       Impact factor: 9.776

8.  Injectable nano-network for glucose-mediated insulin delivery.

Authors:  Zhen Gu; Alex A Aimetti; Qun Wang; Tram T Dang; Yunlong Zhang; Omid Veiseh; Hao Cheng; Robert S Langer; Daniel G Anderson
Journal:  ACS Nano       Date:  2013-05-02       Impact factor: 15.881

Review 9.  Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.

Authors:  Ran Mo; Tianyue Jiang; Jin Di; Wanyi Tai; Zhen Gu
Journal:  Chem Soc Rev       Date:  2014-03-14       Impact factor: 54.564

10.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

View more
  1 in total

Review 1.  Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies.

Authors:  Guanyu Chen; Weirong Kang; Wanqiong Li; Shaomeng Chen; Yanfeng Gao
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.